Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9491985rdf:typepubmed:Citationlld:pubmed
pubmed-article:9491985lifeskim:mentionsumls-concept:C0024660lld:lifeskim
pubmed-article:9491985lifeskim:mentionsumls-concept:C0587900lld:lifeskim
pubmed-article:9491985lifeskim:mentionsumls-concept:C0035331lld:lifeskim
pubmed-article:9491985lifeskim:mentionsumls-concept:C0380301lld:lifeskim
pubmed-article:9491985lifeskim:mentionsumls-concept:C1414304lld:lifeskim
pubmed-article:9491985lifeskim:mentionsumls-concept:C1154402lld:lifeskim
pubmed-article:9491985lifeskim:mentionsumls-concept:C1283195lld:lifeskim
pubmed-article:9491985lifeskim:mentionsumls-concept:C0205224lld:lifeskim
pubmed-article:9491985pubmed:issue2lld:pubmed
pubmed-article:9491985pubmed:dateCreated1998-3-13lld:pubmed
pubmed-article:9491985pubmed:abstractTextEphrin-A5 (AL-1/RAGS), a ligand for Eph receptor tyrosine kinases, repels retinal axons in vitro and has a graded expression in the superior colliculus (SC), the major midbrain target of retinal ganglion cells. These properties implicate ephrin-A5 in the formation of topographic maps, a fundamental organizational feature of the nervous system. To test this hypothesis, we generated mice lacking ephrin-A5. The majority of ephrin-A5-/- mice develop to adulthood, are morphologically intact, and have normal anterior-posterior patterning of the midbrain. However, within the SC, retinal axons establish and maintain dense arborizations at topographically incorrect sites that correlate with locations of low expression of the related ligand ephrin-A2. In addition, retinal axons transiently overshoot the SC and extend aberrantly into the inferior colliculus (IC). This defect is consistent with the high level of ephrin-A5 expression in the IC and the finding that retinal axon growth on membranes from wild-type IC is inhibited relative to that on membranes from ephrin-A5-/- IC. These findings show that ephrin-A5 is required for the proper guidance and mapping of retinal axons in the mammalian midbrain.lld:pubmed
pubmed-article:9491985pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9491985pubmed:languageenglld:pubmed
pubmed-article:9491985pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9491985pubmed:citationSubsetIMlld:pubmed
pubmed-article:9491985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9491985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9491985pubmed:statusMEDLINElld:pubmed
pubmed-article:9491985pubmed:monthFeblld:pubmed
pubmed-article:9491985pubmed:issn0896-6273lld:pubmed
pubmed-article:9491985pubmed:authorpubmed-author:BarbacidMMlld:pubmed
pubmed-article:9491985pubmed:authorpubmed-author:McLaughlinTTlld:pubmed
pubmed-article:9491985pubmed:authorpubmed-author:O'LearyD DDDlld:pubmed
pubmed-article:9491985pubmed:authorpubmed-author:FrisénJJlld:pubmed
pubmed-article:9491985pubmed:authorpubmed-author:FriedmanG CGClld:pubmed
pubmed-article:9491985pubmed:authorpubmed-author:YatesP APAlld:pubmed
pubmed-article:9491985pubmed:issnTypePrintlld:pubmed
pubmed-article:9491985pubmed:volume20lld:pubmed
pubmed-article:9491985pubmed:ownerNLMlld:pubmed
pubmed-article:9491985pubmed:authorsCompleteYlld:pubmed
pubmed-article:9491985pubmed:pagination235-43lld:pubmed
pubmed-article:9491985pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:meshHeadingpubmed-meshheading:9491985-...lld:pubmed
pubmed-article:9491985pubmed:year1998lld:pubmed
pubmed-article:9491985pubmed:articleTitleEphrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and topographic mapping in the mammalian visual system.lld:pubmed
pubmed-article:9491985pubmed:affiliationDepartment of Molecular Oncology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543, USA.lld:pubmed
pubmed-article:9491985pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9491985pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9491985pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:13640entrezgene:pubmedpubmed-article:9491985lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9491985lld:pubmed